How do you pay?

How to pay the least

Cash price

$8,400+ for 30 tablets

Pharmacies pay about this for Icotyde; you’d pay more.

  1. Ask your pharmacy for Icotyde’s cash price, and one or two other pharmacies too.
  2. Icotyde’s savings card works only with insurance from a job or one you bought.

Free from the maker, if you qualify Johnson & Johnson Patient Assistance Program (immunology medicines). Patients’ income must be equal to or less than 400% of Federal Poverty Level (FPL). Or call 1-833-742-0791.

See if you qualify 

No generic is sold yet.

Compare every option

Question
Brand nameIcotyde
Authorized genericicotrokinra
Regular genericicotrokinra
What you’d pay
At least$8,400for 30 tablets; pharmacies pay this
Not soldThere isn’t one
Not soldNone sold yet
Same as Icotyde?
The original
–
–

Brand nameThe maker’s card

ICOTYDE withMe Savings Program

Savings card from Johnson & Johnson

No insuranceNeeds insuranceNo cash price listed.
Insurance · as little as $0 a month

Sign up on jnjwithme.com 

Or call 1-844-494-8463.

In the maker’s words

“For eligible patients using commercial insurance, pay as little as $0 per month.”

From the maker’s offer on jnjwithme.com, checked November 2, 2026. Co-pay cards can’t be used with Medicare (including Medicare Advantage), Medicaid, TRICARE or VA.

Maker’s card or discount card?

A discount card like GoodRx lowers the pharmacy’s cash price, but for a brand-name drug that price often stays high. Compare it with the maker’s card above. You can usually use one or the other on a fill, not both.

Authorized genericNot sold

There isn’t one. An authorized generic is Icotyde itself, from the same company, sold without the brand name, and usually for less. For now Icotyde is the only choice; its maker’s savings card can lower what you pay.

See the brand name →

Regular genericNot sold

No generic is sold yet. Generics usually come once the brand’s patents and exclusivity end. Until then, the maker’s savings card is the way to pay less.

See the brand name →

What it’s used for

What the FDA label says

ICOTYDE is an interleukin-23 (IL-23) receptor antagonist indicated for the treatment of moderate-to-severe plaque psoriasis in adults and pediatric patients 12 years of age and older who weigh at least 40 kg who are candidates for systemic therapy or phototherapy.

Source: the FDA label for Icotyde (Janssen Biotech, Inc.), March 17, 2026. Full label on DailyMed 

Good to know